Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

Open heart surgery for aortic or mitral valve repair or replacement has traditionally required opening the patient’s chest through their sternum (breast bone). In many cases today, a minimally ...

Surgical revision after percutaneous mitral valve repair with a clip: initial multicenter experience. Ann Thorac Surg. 2005 Dec;80(6):2338-42.